 cycling combination antirheumatic drug therapy rheumatoid arthritis open pilot study combination hydroxychloroquine prednisolone alternating months treatment sulphasalazine oral weekly pulse methotrexate patients rheumatoid arthritis RA refractory total disease suppressive medications Results months significant improvements visual analogue score pain joint count Ritchie index scale disability activities daily living ESR rheumatoid factor C-reactive protein degree improvement months commencement treatment Pain score Ritchie index ESR parameters significant improvement months Therapy patients half due efficacy half side effects